OSE Immunotherapeutics Announces Participation In Upcoming Investor Conferences

Nantes, France – September 8, 2022, 6:00pm CEST – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announced today that the leadership team will attend several investor conferences in September and October 2022.

Conference details:

- H.C. Wainwright 24th Annual Global Investment Conference
Format: Fireside chat with H.C. Wainwright’s Equity Research Associate, Sean Lee and
Alexis Vandier, OSE Immunotherapeutics’ Chief Executive Officer
Date: September 12-14, 2022
Location: New York, USA and virtually

- Amsterdam Midcap Event
Format: Investor meetings
Date: September 19, 2022
Location: Virtually

- Investor Access Event
Format: Investor meetings
Date: October 6 & 7, 2022
Location: Paris, FR

- HealthTech Innovation Days
Format: Investor meetings
Date: October 13 & 14, 2022
Location: Paris, FR

- European Midcap Event
Format: Investor meetings
Date: October 17 & 18, 2022
Location: Paris, FR